WARF Therapeutics Seminar – Cary Harding, MD – “Phenylketonuria: Insights into Pathophysiology and Novel Therapeutics”

WARF Therapeutics Seminar

Cary Harding, MD
Oregon Health & Science University
Profile: ohsu.edu/people/cary-o-harding-md

About the Speaker: Dr. Harding is a professor in the Departments of Molecular and Medical Genetics and Pediatrics at Oregon Health & Science University (OHSU). He is board certified in pediatrics, clinical genetics, and biochemical genetics. He received his medical degree from the University of Washington followed by pediatric and medical genetics training at the University of Wisconsin-Madison. Harding is a founding fellow of the American College of Medical Genetics. He is an attending physician on the OHSU clinical genetics service, the clinical genetics clinic, and the metabolic clinic at Doernbecher Children’s Hospital and the medical director of the biochemical genetics laboratory in the Knight Diagnostic Laboratories at OHSU. He is also a clinical consultant to the Northwest Regional Newborn Screening Program and to the State of Idaho Genetics Program. Harding’s basic and clinical research programs are focused upon the development of novel therapies, including gene and cell therapies, for inborn errors of metabolism.

For Further Information, Contact: Clark Kellogg at kellogg@waisman.wisc.edu
The seminar series is funded by the John D. Wiley Conference Center Fund, the Friends of the Waisman Center and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) grant P50HD105353.